Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 28 02:36PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-2.06 Insider Own30.50% Shs Outstand19.17M Perf Week0.21%
Market Cap119.51M Forward P/E- EPS next Y-1.52 Insider Trans0.28% Shs Float17.02M Perf Month-16.15%
Income-43.75M PEG- EPS next Q-0.43 Inst Own62.62% Short Float / Ratio4.24% / 4.80 Perf Quarter-49.17%
Sales53.08M P/S2.25 EPS this Y29.41% Inst Trans17.78% Short Interest0.72M Perf Half Y-51.73%
Book/sh1.25 P/B3.91 EPS next Y20.83% ROA-52.44% Target Price14.40 Perf Year-42.59%
Cash/sh2.38 P/C2.05 EPS next 5Y- ROE-162.49% 52W Range4.23 - 13.18 Perf YTD-57.57%
Dividend- P/FCF- EPS past 5Y-2.37% ROI-61.70% 52W High-62.97% Beta0.92
Dividend %- Quick Ratio4.43 Sales past 5Y60.37% Gross Margin69.08% 52W Low15.23% ATR0.33
Employees173 Current Ratio5.36 Sales Q/Q34.89% Oper. Margin-77.69% RSI (14)34.29 Volatility5.63% 6.41%
OptionableYes Debt/Eq1.33 EPS Q/Q30.00% Profit Margin-82.43% Rel Volume0.75 Prev Close4.97
ShortableYes LT Debt/Eq1.32 EarningsNov 09 AMC Payout- Avg Volume150.39K Price4.88
Recom1.00 SMA20-6.35% SMA50-22.29% SMA200-46.48% Volume90,400 Change-1.81%
Date Action Analyst Rating Change Price Target Change
May-31-22Initiated Lake Street Buy $17
Dec-03-19Initiated Piper Jaffray Overweight
Dec-03-19Initiated JMP Securities Mkt Outperform
Dec-03-19Initiated Jefferies Buy
Dec-03-19Initiated Canaccord Genuity Buy
Nov-16-23 07:00AM
Nov-12-23 12:20PM
Nov-10-23 04:05PM
Nov-09-23 04:05PM
Oct-26-23 07:00AM
04:05PM Loading…
Sep-18-23 04:05PM
Aug-16-23 07:00AM
Aug-11-23 10:03AM
Aug-10-23 09:18AM
Aug-09-23 06:05PM
Aug-04-23 04:02PM
Jul-26-23 07:00AM
Jul-06-23 10:09AM
Jun-18-23 07:51PM
07:00AM Loading…
Jun-15-23 07:00AM
May-25-23 07:00AM
May-21-23 10:30AM
May-19-23 07:00AM
May-12-23 07:44AM
May-11-23 05:25PM
May-09-23 07:00AM
May-08-23 04:30PM
May-02-23 07:00AM
Apr-30-23 08:26AM
Apr-28-23 06:47PM
Apr-27-23 07:00AM
Apr-18-23 11:00PM
04:01PM Loading…
Apr-03-23 06:14AM
Mar-29-23 07:00AM
Mar-24-23 07:15AM
Mar-23-23 07:00AM
Mar-22-23 06:01AM
Mar-21-23 05:15PM
Mar-16-23 07:00AM
Feb-28-23 07:00AM
Feb-24-23 04:02PM
Feb-21-23 07:00AM
Feb-14-23 07:00AM
Jan-20-23 04:05PM
Jan-09-23 07:00AM
Dec-23-22 05:46AM
Dec-21-22 07:00AM
Dec-09-22 04:02PM
Nov-21-22 07:00AM
Nov-12-22 07:42AM
Nov-09-22 05:25PM
Nov-03-22 07:00AM
Oct-28-22 04:05PM
Oct-27-22 07:00AM
Oct-26-22 07:00AM
Oct-24-22 10:24AM
Sep-01-22 07:00AM
Aug-23-22 04:01PM
Aug-19-22 10:52AM
Aug-18-22 04:01PM
Aug-16-22 12:01PM
Aug-15-22 10:20PM
Aug-10-22 10:30PM
Aug-05-22 07:00AM
Aug-04-22 07:00AM
Jul-29-22 04:01PM
Jul-27-22 07:00AM
Jul-20-22 07:00AM
Jul-08-22 06:45AM
Jun-24-22 08:52AM
Jun-23-22 11:02AM
Jun-10-22 06:15AM
Jun-02-22 07:00AM
May-31-22 07:00AM
May-26-22 07:00AM
May-17-22 08:25AM
May-10-22 05:45PM
May-09-22 07:00AM
May-05-22 05:55PM
May-02-22 04:11AM
Apr-29-22 05:00PM
Apr-26-22 07:00AM
Apr-18-22 07:00AM
Mar-30-22 07:00AM
Mar-21-22 05:15PM
Mar-16-22 07:00AM
Mar-08-22 12:42PM
Mar-07-22 04:01PM
Mar-03-22 08:35AM
Feb-28-22 05:45PM
Feb-25-22 04:01PM
Feb-24-22 07:00PM
TELA Bio, Inc. is a commercial stage medical technology company, which focuses on the design, development, and market of tissue reinforcement materials. The company was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KOBLISH ANTONYChief Executive OfficerNov 14Buy4.5411,00049,976303,634Nov 14 08:01 PM
Cuca RobertoCOO and CFONov 14Buy4.4910,00044,93862,371Nov 14 08:02 PM
ORBIMED ADVISORS LLC10% OwnerApr 21Sale9.4127,700260,6572,835,542Apr 21 05:08 PM
ORBIMED ADVISORS LLC10% OwnerApr 20Sale9.4328,300266,8692,863,242Apr 21 05:08 PM
ORBIMED ADVISORS LLC10% OwnerApr 19Sale9.30136,0001,264,8002,891,542Apr 21 05:08 PM
Burgess Vincent JDirectorMar 29Option Exercise4.444,86021,5787,995Mar 31 04:32 PM